{"nctId":"NCT00582010","briefTitle":"Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation","startDateStruct":{"date":"2008-04"},"conditions":["Reperfusion Injury","Liver Injury"],"count":80,"armGroups":[{"label":"1. Experimental","type":"EXPERIMENTAL","interventionNames":["Drug: inhaled nitric oxide"]},{"label":"2. Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: nitrogen gas"]}],"interventions":[{"name":"inhaled nitric oxide","otherNames":["iNO"]},{"name":"nitrogen gas","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients \\> 19 yr of age scheduled to undergo liver transplantation.\n\nExclusion Criteria:\n\n* Patients \\< 19 yr of age\n* Patients undergoing re-transplantation or dual organ transplantation\n* Patients with underlying pulmonary complications","healthyVolunteers":false,"sex":"ALL","minimumAge":"19 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Changed Rate of Liver Function Recovery Post-transplantation (Percent Change in AST Levels)","description":"The faster the percent decrease of AST reflect the greater the treatment improved liver function post transplant. A positive percent reflects an decrease; a negative percentage reflects a increase. The rate was calculated by measuring AST levels at baseline and at 96 hours post baseline. (AST levels were lower at 96 hours relative to baseline- positive values in data table indicate percent decrease of AST relative to baseline).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"83","spread":"14.6"},{"groupId":"OG001","value":"86.4","spread":"18"}]}]}]},{"type":"SECONDARY","title":"Effect of iNO on Hosptial Length of Stay","description":"number of days subject in hospital after surgery until discharge","paramType":"MEAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.0","spread":null},{"groupId":"OG001","value":"9.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Changed Rate of Liver Function Recovery Post-transplantation (Percent Change in ALT Levels)","description":"The faster the percent decrease ALT reflect, the greater the treatment improved liver function post transplant. A positive percent reflects an decrease; a negative percentage reflects a increase. . (ALT levels were lower at 96 hours relative to baseline- positive values in data table indicate percent decrease of ALT relative to baseline).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"62.3","spread":"26.8"},{"groupId":"OG001","value":"62.4","spread":"34.9"}]}]}]},{"type":"PRIMARY","title":"Change in Rate of Liver Function Recovery Post-transplantation (Percent Change in Alkaline Phosphatase Levels)","description":"The faster the percent increase of alkaline phosphatase reflect, the greater the treatment improved liver function post transplant. A positive percent reflects an increase; a negative percentage reflects a decrease.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"239.7","spread":"672.4"},{"groupId":"OG001","value":"55","spread":"96.3"}]}]}]},{"type":"PRIMARY","title":"Change in Rate of Liver Function Recovery Post-transplantation (Percent Change in Prothrombin Times (PT))","description":"The faster the percent increase of PT reflect, the greater the treatment improved liver function post transplant. A positive percent reflects an decrease; a negative percentage reflects a increase.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48.9","spread":"9.9"},{"groupId":"OG001","value":"25.5","spread":"37.4"}]}]}]},{"type":"PRIMARY","title":"Change in Rate of Liver Function Recovery Post-transplantation (Percent Change in Bilirubin Levels)","description":"A positive percent reflects an decrease; a negative percentage reflects a increase.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.6","spread":"57"},{"groupId":"OG001","value":"0.4","spread":"56.7"}]}]}]},{"type":"SECONDARY","title":"Effect of iNO on SICU Stay","description":"Number of minutes after surgery subject remained in SICU","paramType":"MEAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2533","spread":null},{"groupId":"OG001","value":"2518","spread":null}]}]}]},{"type":"PRIMARY","title":"Change in Rate of Liver Function Recovery Post-transplantation (Decrease in Hepatobiliary Complications)","description":"Number of complications due to hepatobiliary events.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Complications Related to Liver Function Recovery Post-transplantation (Total Complications) at 9 Months Post Surgery","description":"Number of any complication reported by subjects at 9 months after surgery","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"44","spread":null},{"groupId":"OG001","value":"83","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":[]}}}